Tags:BioTechChemicalDevelopmentDrugEngineeringIndustryITManufacturingMarketMedicalMedTechPharmacyPlatformProductServiceSmartSpecialtyTechnology
Nanoparticles for accelerated drug development. Collaboration between global pharma and biotech to amplify the effectiveness of New Chemical Entities NCE
Location: Germany, Bavaria, Munich
Total raised: $20.513571M
Founded date: 2011

Investors 4

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
27.07.2015Series A$20.513571...-finsmes.co...

Mentions in press and media 9

DateTitleDescriptionCategoryAuthorSource
26.10.2022Harro Höfl...LEON and Harro Höfliger to bui...--globenewsw...
16.04.2020leon-nanod...leon-nanodrugs GmbH, a Munich,...Germany-finsmes.co...
09.01.2017leon Appoi...leon nanodrugs GmbH appoints p...--signetheal...
09.01.2017leon Appoi...leon nanodrugs GmbH appoints p...--tvm-lifesc...
17.08.2015Leon-nanod...TVM Capital Life Science leads...--signetheal...
29.07.2015Munich´s l...leon nanodrugs GmbH today anno...--bio-m.org/...
27.07.2015leon nanod...leon nanodrugs GmbH, a Munich,...Germany-finsmes.co...
27.07.2015Daily fund...Palantir received $450M; Draft...-Mitos Suso...vator.tv/n...
27.07.2015leon-nanod...TVM Capital Life Science leads...--tvm-lifesc...